Protecting intellectual property is vital for medical innovation, says UK reportBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1238 (Published 30 January 2014) Cite this as: BMJ 2014;348:g1238
- Jacqui Wise
Protecting intellectual property rights is vital to ensuring biomedical innovation and protecting patients’ interests, a report from University College London’s School of Pharmacy has concluded.1
The report said that, without intellectual property rights, private investment in high risk biomedical research would be very unlikely to take place and that this would have negative knock-on effects on public funding for fundamental research. It added that additional changes should be introduced to incentivise research in neglected fields such as drugs for rare diseases.
The report, which was produced in partnership with the International Alliance of Patients’ Organizations, said that there was a case for extending the periods of intellectual property protection for new …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial